Prestige Consumer HealthcarePBH
Market Cap: $3.65B
About: Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Employees: 570
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
588% more call options, than puts
Call options by funds: $330K | Put options by funds: $48K
3.88% more ownership
Funds ownership: 98.38% [Q1] → 102.26% (+3.88%) [Q2]
9% more repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 106
1% less funds holding
Funds holding: 307 [Q1] → 303 (-4) [Q2]
7% less capital invested
Capital invested by funds: $3.76B [Q1] → $3.51B (-$251M) [Q2]
11% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 38
50% less funds holding in top 10
Funds holding in top 10: 2 [Q1] → 1 (-1) [Q2]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
DA Davidson Linda Bolton Weiser 38% 1-year accuracy 33 / 88 met price target | 30%upside $95 | Buy Maintained | 28 Aug 2024 |
DA Davidson Linda Bolton Weiser 38% 1-year accuracy 33 / 88 met price target | 27%upside $93 | Buy Maintained | 9 Aug 2024 |
Financial journalist opinion
Based on 4 articles about PBH published over the past 30 days